CDSCO issues alert against 62 substandard drugs; Samples from Lupin, Jackson Laboratories flagged

The Central Drugs Standard Control Organisation (CDSCO) has flagged 62 drug samples as they failed the quality test. The alert was issued by the drug regulator for November 2023.

The drug regulator’s list, as seen by Financial Express.com, reveals that 1197 drug samples were tested, out of which 1133 samples were of standard quality. 62 samples were not of standard quality, one sample was spurious and one sample was misbranded.

The list includes common drugs like Cefixime, Azithromycin and Lactic Acid Bacillus Tablets, paracetamol tablets, Albendazole Tablets, Methylcobalamin injection, Ceftriaxone injection, Methotrexate injection among other.

According to the drug regulator, dissolution, disintegration and assay are some of the reason of drug test failure. Lupin, Jackson Laboratories, E.G. Pharmaceuticals, Konis Pharmaceuticals, Biozenta Lifesciences Pvt., Aristo Pharmaceuticals, and Cotec Healthcare are some of the companies whose drug failed the quality test.

The regulator also issued a revised drug Alert for May 2022 which Omeprazole (Delayed-Release) and Domperidone (Sustained Release) Capsules, manufactured by Dr. Reddy’s Laboratories. CDSCO maintains that the assay of Omeprazole and Domperidone is the reason of failure.

“The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. Thus, the product is purported to be spurious, however, the same is subject to outcome of investigation,” it stated.

The drug combination belongs to a group of medicines called gastrointestinal agents used to treat heartburn, indigestion, epigastric pain, gastro-oesophageal reflux disease (GERD), peptic ulcers and Zollinger-Ellison syndrome.

Related Posts

  • Pharma
  • December 21, 2024
  • 145 views
Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

Bengaluru: The Karnataka government has initiated prosecution against Paschim Banga Pharmaceuticals after five women died following C-section deliveries in Ballari district, where they were administered the company’s IV fluid. Health Minister…

  • Pharma
  • December 21, 2024
  • 198 views
NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

New Delhi:  The National Pharmaceutical Pricing Authority (NPPA) has notified ceiling price fixation of 13 scheduled formulations, retail price fixation of 65 new drugs against applications from individual companies, and…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt

Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt

Telangana DCA Cracks Down On Illegal Drug Practices

Telangana DCA Cracks Down On Illegal Drug Practices

Pune: Two Arrested For Selling Illegal Steroid Injections In Gyms

Pune: Two Arrested For Selling Illegal Steroid Injections In Gyms

Serum To Make Chikungunya Vaccine In India

Serum To Make Chikungunya Vaccine In India